Clinical trial
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
NCT00095446 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00095446 |
|---|---|
| Title | NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes |
| Official title | An Open-Label, Multi Center, Clinical Trial: External Continuous Subcutaneous Infusion of Insulin Using Insulin Aspart (NovoLog®) in Subjects With Type 1 and Insulin Requiring Type 2 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1, Type 2 |
| Intervention type | Drug |
| Interventions | insulin aspart |
| Enrollment | 513 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Nov 5, 2004 |
| Last update posted | Jan 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: